Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global Webinars
暂无分享,去创建一个
Kazuhiro Yoshida | D. Kerr | R. Schilsky | J. Warner | G. Curigliano | L. Pierce | J. Soria | J. García-Foncillas | S. Chan | Jeeyun Lee | A. Jazieh | L. Horn | A. Nogueira-Rodrigues | T. Gilmore | C. Mathias | N. Dickson | Á. Rogado | V. Eaton
[1] J. Warner,et al. Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study , 2020, Cancer discovery.
[2] C. Swanton,et al. Cancer Research: The lessons to learn from COVID-19. , 2020, Cancer discovery.
[3] J. Yarnold,et al. Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Shetal I Shah,et al. COVID-19 impact on research, lessons learned from COVID-19 research, implications for pediatric research , 2020, Pediatric Research.
[5] V. Torri,et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study , 2020, The Lancet Oncology.
[6] Alokkumar Jha,et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study , 2020, The Lancet.
[7] B. Ebert,et al. The impact of the COVID-19 pandemic on cancer care , 2020, Nature Cancer.
[8] A. Jazieh. Managing Healthcare Workers During the COVID-19 Pandemic and Beyond. , 2020, Global journal on quality and safety in healthcare.
[9] J. Warner,et al. The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer , 2020, Cancer Cell.
[10] E. Sawyer,et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial , 2020, The Lancet.
[11] S. Formenti,et al. Cancer and COVID-19 — potentially deleterious effects of delaying radiotherapy , 2020, Nature Reviews Clinical Oncology.
[12] S. Nagesh,et al. Saving the frontline health workforce amidst the COVID-19 crisis: Challenges and recommendations , 2020, Journal of global health.
[13] P. Pharoah,et al. Collateral damage: the impact on cancer outcomes of the COVID-19pandemic , 2020, medRxiv.
[14] S. Fröhling,et al. Caring for patients with cancer in the COVID-19 era , 2020, Nature Medicine.
[15] Andrew K. Przybylski,et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science , 2020, The Lancet Psychiatry.
[16] COVIDSurg Collaborative. Global guidance for surgical care during the COVID-19 pandemic , 2020, The British journal of surgery.
[17] E. Tapper,et al. The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care , 2020, Journal of Hepatology.
[18] E. Basch,et al. Oncology Practice During the COVID-19 Pandemic. , 2020, JAMA.
[19] Yan Guo,et al. Fighting against the common enemy of COVID-19: a practice of building a community with a shared future for mankind , 2020, Infectious Diseases of Poverty.
[20] T. Shanafelt,et al. Understanding and Addressing Sources of Anxiety Among Health Care Professionals During the COVID-19 Pandemic. , 2020, JAMA.
[21] G. Curigliano,et al. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID‐19) Pandemic: An International Collaborative Group , 2020, The oncologist.
[22] Prabhas V. Moghe,et al. The COVID-19 pandemic and research shutdown: staying safe and productive. , 2020, The Journal of clinical investigation.
[23] T. Burki. Cancer guidelines during the COVID-19 pandemic , 2020, The Lancet Oncology.
[24] C. Booth,et al. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic , 2020, Nature Reviews Clinical Oncology.
[25] R. Fisher,et al. A War on Two Fronts: Cancer Care in the Time of COVID-19 , 2020, Annals of Internal Medicine.
[26] M. Knoll,et al. The Impact of COVID-19 on Radiation Oncology Clinics and Patients With Cancer in the United States , 2020, Advances in Radiation Oncology.
[27] A. Ravaud,et al. The official French guidelines to protect patients with cancer against SARS-CoV-2 infection , 2020, The Lancet Oncology.
[28] John P. A. Ioannidis,et al. Coronavirus disease 2019: The harms of exaggerated information and non‐evidence‐based measures , 2020, European journal of clinical investigation.
[29] R. Walls,et al. Supporting the Health Care Workforce During the COVID-19 Global Epidemic. , 2020, JAMA.
[30] J. Hollander,et al. Virtually Perfect? Telemedicine for Covid-19. , 2020, The New England journal of medicine.
[31] A. Jazieh,et al. Managing Oncology Services During a Major Coronavirus Outbreak: Lessons From the Saudi Arabia Experience , 2020, JCO global oncology.
[32] Min Chen,et al. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus , 2020, The Lancet Psychiatry.
[33] Ana Maria Lopez,et al. Telemedicine in Cancer Care. , 2018, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
[34] E. Susser,et al. The Psychological Impact of the SARS Epidemic on Hospital Employees in China: Exposure, Risk Perception, and Altruistic Acceptance of Risk , 2009, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[35] C. Tournigand,et al. OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.